biomarker detection Nov 23, 2022 Higher TIL Levels in Residual Disease May Predict Worse Survival in HER2-Positive Breast Cancer Premium Nov 17, 2022 Biomarker Predicts Immunotherapy Benefit in Head and Neck Cancer but Commercial Path Unclear Premium Oct 20, 2022 GE Healthcare Educating Docs on Guidelines-Backed Use of Imaging Agent for ER-Positive Breast Cancer Premium Oct 19, 2022 UCLA Researchers Suggest Simple Metabolic Biomarker May Predict CAR T-Cell Toxicities Premium Oct 19, 2022 Veto of California Bill Mandating Payor Coverage of Biomarker Tests Sparks Stakeholder Debate Premium Oct 17, 2022 Singapore Institutions Launch Program to Diagnose, Treat EBV-Associated Nasopharyngeal Cancer Oct 13, 2022 Tavros Therapeutics, Bayer Subsidiary Vividion Ink Precision Oncology Deal Oct 11, 2022 ONI, UPenn Partner on Microscopy-Based CAR T-Cell Therapy Biomarker Research Oct 7, 2022 Swiss Biotech PreComb Therapeutics Wants to Automate Functional Precision Medicine Premium Oct 5, 2022 Massive Bio, Perthera Partner on Biomarker-Based Clinical Trial Matching Sep 30, 2022 Tumor-Only Sequencing Found to Overestimate Mutational Burden in Non-European Patients Sep 27, 2022 Tavros Therapeutics Raises $7.5M to Advance Biomarker-Directed Cancer Drug Discovery Platform Sep 20, 2022 Transcriptomics Plus 'Immune Tolerance' of Normal Tissue Shows Promise in Lung Cancer Prognosis Premium Sep 13, 2022 Imaging Agent May Have Potential as Noninvasive Test to Predict PARP Inhibitor Response Sep 10, 2022 BMS Combo Drug Opdualag Effective in Neoadjuvant NSCLC, But Maybe No Better Than Opdivo Alone Premium Sep 7, 2022 Isofol Medical Halts Colon Cancer Study After Negative Readout; Continues Subgroup Analyses Aug 8, 2022 NHS Should Offer Genetic Profiling to All Cancer Patients in UK, Experts Say Jul 28, 2022 Turning Point Therapeutics Receives Positive FDA Feedback on Repotrectinib NSCLC Application Jul 28, 2022 Canadian Nurse Navigator-Led Program Aims to Improve Breast Cancer Genomic Test Access Premium Jul 12, 2022 NCCN Publishes First Guidelines for Pediatric Brain Cancer, Recommends Broad NGS Profiling Load More Breaking News Marengo Therapeutics Begins Phase I/II Trial of Selective T-Cell-Targeted Antibody Janssen, Legend Biotech's Carvykti Bests Chemo in Earlier-Line Multiple Myeloma Trial In Brief This Week: PreludeDx, Johnson & Johnson, Syros, Magenta, Merck NICE Backs Gilead Sciences' Yescarta as Third-Line Option for Lymphoma Patients BMS Eyeing Breyanzi Indications in CLL, SLL After Positive Trial Data Enhertu Approved in Europe for HER2-Low Metastatic Breast Cancer
